Li-Wei (Vincent) Wu, B.Pharm., M.S.

Li Wei Wu

Graduate Student

Entry into the Program: Fall 2024

Pronouns: He/Him

Advising Professor: Dr. Chanhyun Park

Education

  • M.S. Pharmacy, National Defense Medical Center, Taipei, Taiwan
  • B.S. Pharmacy, National Defense Medical Center, Taipei, Taiwan

Research Interests

  • Clinical Outcomes, Economic Evaluation, Health Technology Assessment, Pharmacoepidemiology

Publications

  • Wu LW, LD MA, Okoye BI, Park C. Machine learning-based prediction of cardiovascular adverse events in patients with cancer: a systematic review. Expert Review of Pharmacoeconomics & Outcomes Research. 2026:1-18.
  • Wu LW, Heo JH, Fa A, Ng BP, Park C. Healthcare cost trajectories among patients with cancer and cardiometabolic comorbidities over a decade including the pandemic period. Journal of Managed Care & Specialty Pharmacy. 2026;32(4):445-457.
  • Wu LW, Lin TC, Lin TH, Liou YJ, Tsai CL, Yang KY, Wang MT. Comparative effectiveness and safety of escalating to triple therapy versus switching to dual bronchodilators after discontinuing LABA/ICS in patients with COPD: a retrospective cohort study. Therapeutic Advances in Respiratory Disease. 2024 Jan-Dec:18:17534666241292242.
  • Pan HY, Wu LW, Wang PC, Chiu PH, Wang MT. Real-world evidence of the herb-drug interactions. Journal of Food and Drug Analysis. 2022;30(3):316-330.
  • Wang MT, Pan HY, Huang YL, Wu LW, Wang PC, Hsu YJ, Lin TC, Lin CW, Lai JH, Lee CH. Comparison of mitochondrial adenosine triphosphate-sensitive potassium channel high- vs low-affinity sulfonylureas and cardiovascular outcomes in patients with type 2 diabetes treated with metformin. JAMA Network Open. 2022;5(12):e2245854.
  • Hsueh-Yi Pan, Li-Wei Wu, Pin-Chun Wang, Ping-Hung Chiu, Meng-Ting Wang*. Real-world Evidence of the Herb-drug Interactions. Journal of Food and Drug Analysis. 2022;30(3):316-330.

Presentations

  • Wu LW, Kim Y, Park C. Prevalence of cardiovascular-kidney-metabolic syndrome among older women with breast cancer in the 2011-2021 SEER-Medicare data. International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual Meeting, Philadelphia, PA, USA, May 2026.
  • Kim Y, Wu LW, Kumaraswamy N, Park C. Algorithmic fairness in machine learning prediction for long-term adjuvant endocrine therapy adherence among breast cancer survivors. Center for Health Promotion and Disease Prevention Research in Underserved Populations (CHPR) Annual Conference, Austin, TX, USA, March 2026.
  • Nguyen KV, Wu LW, Park C, Stewart M, Nohria R. Tag, you are it: evaluating artificial intelligence and faculty alignment in question categorization across four competency frameworks. American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting, Las Vegas, NV, USA, December 2025.
  • Lewis A, Mann A, Park C, Wu LW. Antiretroviral therapy adherence after removal of the cost barrier. AMCP Annual Meeting, Houston, TX, USA, April 2025.
  • Wu LW, Fa A, Park C. Trends in healthcare costs over a decade among patients with cancer and cardiometabolic comorbidities. Academy of Managed Care Pharmacy (AMCP) Annual Meeting, Houston, TX, USA, April 2025. (AMCP Foundation Graduate Student Best Poster Award).

Contact Information

Why UTCOP HOD?

  • UTCOP HOD provides diverse research training, along with experienced and approachable faculty members and students.

What do you enjoy outside of school?

  • Exploring the food and sights in Austin, watching movies, and working out.